Macular degeneration – Diagnostics – Overview of Information and Clinical Research

Diagnosing macular degeneration is the first step toward protecting your vision. Early detection through regular eye examinations can help identify changes in your eyes before you notice any problems with your sight, and understanding the different tests available helps you know what to expect when you visit your eye doctor.

Who Should Seek Diagnostic Testing for Macular Degeneration

If you are age 55 or older, regular eye examinations become increasingly important because your risk for age-related macular degeneration (AMD) rises as you get older. The term refers to a condition where the macula, the central part of the retina at the back of your eye, begins to deteriorate. This part of your eye is responsible for sharp, straight-ahead vision that you need for reading, recognizing faces, and driving.^[1]

People over the age of 60 face the highest risk, making macular degeneration a leading cause of vision loss in this age group. However, you should not wait until you are in your sixties to start paying attention. Anyone age 55 and above should make eye exams a regular part of their healthcare routine.^[2]

Certain factors beyond age can place you at higher risk and make early diagnostic testing even more important. If anyone in your family has had macular degeneration, you face a greater chance of developing it yourself. Being Caucasian also increases your risk. Lifestyle factors matter as well. If you smoke, have high blood pressure, are overweight, or eat a diet high in saturated fats, you are more vulnerable to developing this eye condition.^[1]

⚠️ Important

Early macular degeneration does not cause any symptoms. You cannot rely on changes in your vision to tell you when something is wrong. This is why regular eye exams are essential, especially if you are at risk due to age, family history, or other factors. Do not wait for your vision to change before scheduling an appointment with your eye doctor.^[2]

You should see your eye doctor right away if you notice certain warning signs, even if you do not fall into a high-risk category. If straight lines begin to appear wavy or crooked, this is a serious symptom that requires immediate attention. A blurry area near the center of your vision, trouble seeing in low lighting, or colors appearing less bright than before are other signs that should prompt you to seek help.^[2]

People who notice mild blurriness in their central vision or have difficulty seeing in dim light may already have intermediate-stage dry macular degeneration, even though some people at this stage experience no symptoms at all. By the time you reach late-stage disease, many people see blank spots in their central vision or notice that the blurry area is getting bigger over time.^[2]

Classic Diagnostic Methods Used to Identify Macular Degeneration

When you visit an eye doctor with concerns about macular degeneration or for a routine screening, the examination process begins with a review of your medical and family history. Your doctor will ask about any symptoms you have noticed and whether anyone in your family has been diagnosed with macular degeneration. This background information helps guide the testing process.^[8]

A complete eye examination is the cornerstone of diagnosing macular degeneration. Your eye doctor will use drops to dilate your pupils, making them wider so that the back of your eye can be examined more easily. Using a special tool, the doctor examines the back of your eye, looking for specific signs of macular degeneration. One key sign is a mottled appearance caused by yellow deposits called drusen, which form under the retina. People with macular degeneration often have many of these deposits. The presence and size of drusen help determine what stage of the disease you may have.^[8]

The Amsler grid test is a simple but valuable tool used to detect changes in your central vision. During this test, you look at a grid of straight lines and report what you see. If you have macular degeneration, some of the straight lines may appear faded, broken, or distorted. You may also notice a blank spot near the center of the grid. This test helps identify problems with your macula that affect how you see shapes and details directly in front of you.^[8]

If your doctor needs more detailed information about the blood vessels in your eye, they may perform fluorescein angiography. In this test, a special dye is injected into a vein in your arm. The dye travels through your bloodstream and eventually reaches the blood vessels in your eyes. A special camera takes pictures as the dye moves through these vessels, creating images that show whether there are any changes or abnormalities in the retina or blood vessels. These images can reveal damage or leaking that might not be visible during a standard eye exam.^[8]

A similar test called indocyanine green angiography also uses an injected dye to visualize blood vessels. It may be used alongside fluorescein angiography to provide additional information, particularly when your doctor needs a more complete picture of what is happening beneath the retina.^[8]

These imaging tests are particularly important for distinguishing between the two main types of macular degeneration: dry and wet. Nearly 90 percent of people with macular degeneration have the dry form, where drusen deposits cause the macula to thin and dry out. Vision loss from dry macular degeneration usually happens gradually. The wet form, which affects about 10 percent of cases, is more severe. It occurs when abnormal blood vessels grow under the retina and macula, leaking blood and fluid. This causes a bulge in the macula, and you may see dark spots in your central vision. Wet macular degeneration can quickly lead to significant loss of central vision.^[1]

Dry macular degeneration progresses through three stages: early, intermediate, and late. In the early stage, your macula changes but your vision is not affected, which is why you may not know you have it without an eye exam. In the intermediate stage, vision may become blurry or wavy. By the late stage, central vision fails completely. Wet macular degeneration is always considered an advanced stage of the disease.^[1]

⚠️ Important

Macular degeneration may develop in one eye or both eyes, and the severity can differ between eyes. Your peripheral vision, which is your ability to see things off to the sides, remains intact. You will not go completely blind from macular degeneration, but losing your central vision can make daily activities like reading, driving, and recognizing faces much more difficult.^[1]

The diagnostic process helps your doctor not only identify whether you have macular degeneration but also determine which type and stage you have. This information is crucial because it guides treatment decisions and helps predict how your vision may change over time.

Diagnostic Testing for Clinical Trial Qualification

Clinical trials for macular degeneration require specific diagnostic criteria to ensure that participants are appropriate candidates for the treatments being studied. These studies typically involve detailed eye examinations similar to those used in standard diagnosis, but they may include additional measurements and more frequent testing to track how the disease responds to experimental treatments.

Participants in clinical trials generally must have their disease stage confirmed through comprehensive eye exams, including dilated eye examinations where the back of the eye is carefully studied. Imaging tests such as fluorescein angiography may be required to document the condition of blood vessels in the retina and confirm whether someone has wet macular degeneration with active leaking vessels, or whether they have the dry form with drusen deposits but no abnormal vessel growth.^[8]

Researchers conducting clinical trials need precise baseline measurements of vision and retinal health so they can accurately measure whether a treatment is working. This means that trial participants may undergo more frequent Amsler grid testing, repeated imaging studies, and detailed visual acuity measurements throughout the study period. These measurements help determine whether the experimental treatment is slowing disease progression, stabilizing vision, or in some cases improving visual function.

The National Eye Institute supports clinical trials for macular degeneration, including research on stem cell transplants for dry macular degeneration. Such studies require thorough diagnostic evaluations both before enrollment and throughout the trial to monitor safety and effectiveness.^[2]

Trial eligibility often depends on specific characteristics of your disease. For example, some trials may only accept participants with intermediate-stage dry macular degeneration, while others may focus on people with wet macular degeneration who have not yet received treatment. The stage of your disease, the presence or absence of specific retinal changes, and even the size and number of drusen deposits can determine whether you qualify for a particular study.

If you are interested in participating in a clinical trial, your eye doctor will perform the necessary diagnostic tests to determine whether you meet the criteria. These tests ensure that researchers can accurately study the treatment’s effects and that participants receive appropriate care throughout the trial period.

Prognosis and Survival Rate

Prognosis

The outlook for people with macular degeneration varies depending on which type you have and how quickly it progresses. Dry macular degeneration, which affects nearly 90 percent of people with the condition, tends to progress slowly over several years. Many people with the dry form maintain relatively good vision for a long time, and most do not completely lose their central vision.^[1]

The disease progresses through early, intermediate, and late stages. In the early stage, your macula changes but vision remains unaffected. Some people never progress beyond this stage. Others move to the intermediate stage where vision may become blurry or wavy, though some people still experience no symptoms at this point. Late-stage dry macular degeneration can result in complete loss of central vision, but this happens gradually, giving you time to adapt and learn new ways of managing daily tasks.^[1]

Wet macular degeneration, though less common, is more serious because it can cause faster vision loss. It develops when abnormal blood vessels grow under the retina and leak blood and fluid, damaging the macula. Any stage of dry macular degeneration can turn into the wet form, which is always considered late-stage disease. The good news is that treatment options are available for wet macular degeneration that can slow vision loss in many cases.^[2]

Importantly, macular degeneration does not cause complete blindness. Your peripheral vision remains intact, meaning you can still see things off to the sides. While central vision loss can make activities like reading, driving, and recognizing faces more difficult, people with macular degeneration can learn to use their remaining vision effectively. Visual rehabilitation, low-vision aids, and lifestyle adaptations help many people maintain independence and quality of life.^[1]

Several factors influence your prognosis. If you have a family history of macular degeneration, smoke, have high blood pressure, are overweight, or eat a diet high in saturated fats, your disease may progress more quickly. Making lifestyle changes such as quitting smoking, controlling blood pressure, maintaining a healthy weight, and eating a diet rich in leafy green vegetables and fish may help slow progression.^[1]

Survival rate

Macular degeneration is not a life-threatening condition. It affects vision but does not directly impact survival. The disease does not cause death, and people with macular degeneration have normal life expectancies. The condition is primarily a concern for quality of life and independence rather than survival.

However, the impact on daily living can be significant. Age-related macular degeneration is a leading cause of vision loss in Americans aged 65 and older, and worldwide it is estimated that around 200 million people are living with the condition, a number expected to reach 288 million by 2040.^[6]

The risk of developing advanced macular degeneration increases from about 2 percent for people ages 50 to 59, to nearly 30 percent for those over age 75. This means that as you live longer, your chances of experiencing vision loss from macular degeneration increase, but with proper management and support, most people continue to live independently and maintain good quality of life.^[5]

#1 Clinical Trials Search in Europe